Post-marketing Safety Study of mRNA-1283 in the United States

Study identification

• EU PAS number:
  EUPAS1000000971
• Study ID:
  1000000971
• Official title and acronym:
  Post-marketing Safety Study of mRNA-1283 in the United States
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  No information provided.
• Study status:
  Planned

Research institutions and networks

Institutions

RTI Health Solutions (RTI-HS)

France

Spain

Sweden

United Kingdom

United Kingdom (Northern Ireland)

United States

ModernaTx

Study timelines

Date when funding contract was signed

Actual:04/04/2025

Study start date

Planned:15/06/2026

Date of final study report

Planned:30/09/2029

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)

Other study registration identification numbers and links

mRNA-1283-P901